Go
Print

These documents are currently being revised to incorporate the changes made during the 2024 Legislative Session. Please consult the Sections Affected Table for changes made during the 2024 Legislative Session.

Chapter 43.71C RCW

PRESCRIPTION DRUG COSTS

Sections

HTMLPDF 43.71C.010Definitions.
HTMLPDF 43.71C.020Health carriers—Cost and utilization data reporting.
HTMLPDF 43.71C.030Pharmacy benefit managers—Data reporting.
HTMLPDF 43.71C.040Pharmacy benefit managers—Compliance.
HTMLPDF 43.71C.050Manufacturers—Data reporting.
HTMLPDF 43.71C.060Manufacturers—Notice of new drug applications.
HTMLPDF 43.71C.070Manufacturers—Notice of price increases.
HTMLPDF 43.71C.080Pharmacy services administrative organizations—Data reporting.
HTMLPDF 43.71C.090Enforcement.
HTMLPDF 43.71C.100Annual report—Data confidentiality.
HTMLPDF 43.71C.110Rule making.
HTMLPDF 43.71C.800Joint state strategies—Development and implementation recommendations.
HTMLPDF 43.71C.900Findings—2019 c 334.
Site Contents
Selected content listed in alphabetical order under each group



Translate